β-carotene Supplementation and Lung Cancer Incidence in the ATBC Study: the Role of Tar and Nicotine

β-carotene Supplementation and Lung Cancer Incidence in the ATBC Study: the Role of Tar and... Abstract Introduction The Alpha-Tocopherol, Beta-Carotene Cancer Prevention (ATBC) Study demonstrated that β-carotene supplementation increases lung cancer incidence in smokers. Further, cigarettes with higher tar and nicotine content are associated with a higher risk of lung cancer. However, no studies have examined whether the increased risk associated with β-carotene supplementation in smokers varies by the tar or nicotine content of cigarettes. Methods The ATBC Study was a randomized, double-blind intervention trial conducted in southwest Finland. 29,133 male smokers, aged 50-69 years were enrolled and randomly assigned to one of four groups (α-tocopherol, β-carotene, both, or placebo). Cox proportional hazards models were used to estimate the hazard ratio (HR) and 95% confidence intervals (CI) of lung cancer risk by β-carotene trial assignment stratified by a priori categories of cigarette tar and nicotine content. Results The β-carotene supplementation group had significantly higher risk of developing lung cancer in all categories of tar content [yes versus no β-carotene supplementation - ultra-light cigarettes (≤7 mg tar): HR=1.31 95% CI=0.91-1.89; non-filtered cigarettes (≥21 mg tar): HR=1.22 95% CI=0.91-1.64; p for interaction=0.91]. Similarly, there was no interaction with nicotine content [yes versus no β-carotene supplementation - ventilated cigarettes (≤0.8 µg nicotine) HR=1.23, 95% CI=0.98-1.54; non-filtered cigarettes (≥1.3 µg nicotine): HR=1.22, 95% CI=0.91-1.64; p for interaction=0.83]. Conclusion These findings support the conclusion that supplementation with β-carotene increases the risk of lung cancer in smokers regardless of the tar or nicotine content of cigarettes smoked. Our data suggest that all smokers should continue to avoid β-carotene supplementation. Implications Previous studies demonstrated that β-carotene supplementation increases risk of lung cancer in smokers. This study moves the field forward by examining the potential for modification of risk of lung cancer with different levels of tar and nicotine in cigarettes smoked, as interaction with carcinogens in these components of cigarette smoke are hypothesized to be the mechanism by which β-carotene increases risk.  Our study provides evidence that the increased risk of lung cancer in smokers who take β-carotene supplements is not dependent upon the tar or nicotine level of cigarettes smoked and suggests that all smokers should continue to avoid β-carotene supplementation. Published by Oxford University Press on behalf of the Society for Research on Nicotine and Tobacco 2018. This work is written by (a) US Government employee(s) and is in the public domain in the US. This work is written by (a) US Government employee(s) and is in the public domain in the US. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Nicotine and Tobacco Research Oxford University Press

β-carotene Supplementation and Lung Cancer Incidence in the ATBC Study: the Role of Tar and Nicotine

Loading next page...
 
/lp/ou_press/carotene-supplementation-and-lung-cancer-incidence-in-the-atbc-study-7jzh4UZtMp
Publisher
Oxford University Press
Copyright
Published by Oxford University Press on behalf of the Society for Research on Nicotine and Tobacco 2018. This work is written by (a) US Government employee(s) and is in the public domain in the US.
ISSN
1462-2203
eISSN
1469-994X
D.O.I.
10.1093/ntr/nty115
Publisher site
See Article on Publisher Site

Abstract

Abstract Introduction The Alpha-Tocopherol, Beta-Carotene Cancer Prevention (ATBC) Study demonstrated that β-carotene supplementation increases lung cancer incidence in smokers. Further, cigarettes with higher tar and nicotine content are associated with a higher risk of lung cancer. However, no studies have examined whether the increased risk associated with β-carotene supplementation in smokers varies by the tar or nicotine content of cigarettes. Methods The ATBC Study was a randomized, double-blind intervention trial conducted in southwest Finland. 29,133 male smokers, aged 50-69 years were enrolled and randomly assigned to one of four groups (α-tocopherol, β-carotene, both, or placebo). Cox proportional hazards models were used to estimate the hazard ratio (HR) and 95% confidence intervals (CI) of lung cancer risk by β-carotene trial assignment stratified by a priori categories of cigarette tar and nicotine content. Results The β-carotene supplementation group had significantly higher risk of developing lung cancer in all categories of tar content [yes versus no β-carotene supplementation - ultra-light cigarettes (≤7 mg tar): HR=1.31 95% CI=0.91-1.89; non-filtered cigarettes (≥21 mg tar): HR=1.22 95% CI=0.91-1.64; p for interaction=0.91]. Similarly, there was no interaction with nicotine content [yes versus no β-carotene supplementation - ventilated cigarettes (≤0.8 µg nicotine) HR=1.23, 95% CI=0.98-1.54; non-filtered cigarettes (≥1.3 µg nicotine): HR=1.22, 95% CI=0.91-1.64; p for interaction=0.83]. Conclusion These findings support the conclusion that supplementation with β-carotene increases the risk of lung cancer in smokers regardless of the tar or nicotine content of cigarettes smoked. Our data suggest that all smokers should continue to avoid β-carotene supplementation. Implications Previous studies demonstrated that β-carotene supplementation increases risk of lung cancer in smokers. This study moves the field forward by examining the potential for modification of risk of lung cancer with different levels of tar and nicotine in cigarettes smoked, as interaction with carcinogens in these components of cigarette smoke are hypothesized to be the mechanism by which β-carotene increases risk.  Our study provides evidence that the increased risk of lung cancer in smokers who take β-carotene supplements is not dependent upon the tar or nicotine level of cigarettes smoked and suggests that all smokers should continue to avoid β-carotene supplementation. Published by Oxford University Press on behalf of the Society for Research on Nicotine and Tobacco 2018. This work is written by (a) US Government employee(s) and is in the public domain in the US. This work is written by (a) US Government employee(s) and is in the public domain in the US.

Journal

Nicotine and Tobacco ResearchOxford University Press

Published: Jun 8, 2018

There are no references for this article.

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Search

Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly

Organize

Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.

Access

Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

DeepDyve

Freelancer

DeepDyve

Pro

Price

FREE

$49/month
$360/year

Save searches from
Google Scholar,
PubMed

Create lists to
organize your research

Export lists, citations

Read DeepDyve articles

Abstract access only

Unlimited access to over
18 million full-text articles

Print

20 pages / month

PDF Discount

20% off